Hutten DR, Bos JHJ, de Vos S, Hak E, et al. Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer's Disease: A Retrospective Inception Cohort Study. J Alzheimers Dis 2022 Apr 18. pii: JAD215057. doi: 10.3233/JAD-215057.
PMID: 35466934